ArticlePediatrics2015
Trends in Emergency Department Visits for Unsupervised Pediatric Medication Exposures, 2004-2013.
Article in Pediatrics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
30 citing papers in PubMed.
- Racial/Ethnic and Regional Disparities in Opioid-Involved Overdose Deaths among Children and Adolescents in the United States.Journal of racial and ethnic health disparities · 2026Article
- US Emergency Department Visits for Antibiotic Adverse Drug Events in Children, 2019-2023.Journal of the Pediatric Infectious Diseases Society · 2026Article
- Article
- Patient Information Needs During Ambulatory Medication Changes: A Qualitative Study.Journal of patient-centered research and reviews · 2025Article
- Assessment of acute poisoning in children using poisoning severity scores: A cross-sectional study at Damietta General Hospital Egypt.Toxicology reports · 2024Article
- Misuse, Abuse and Medication Errors' Adverse Events Associated with Opioids-A Systematic Review.Pharmaceuticals (Basel, Switzerland) · 2024Review
- Notes from the Field: Emergency Department Visits for Unsupervised Pediatric Melatonin Ingestion - United States, 2019-2022.MMWR. Morbidity and mortality weekly report · 2024Article
- Article
- Trends in Emergency Department Visits for Unsupervised Pediatric Medication Exposures.American journal of preventive medicine · 2023Article
- Childhood Poisoning During the COVID-19 Pandemic.Turkish archives of pediatrics · 2023Article
- Article
- The Impact of Pediatric Opioid-Related Visits on U.S. Emergency Departments.Children (Basel, Switzerland) · 2022Article
- Medication Use and Storage, and Their Potential Risks in US Households.Pharmacy (Basel, Switzerland) · 2022Article
- Pediatric drug overdose mortality: contextual and policy effects for children under 12 years.Pediatric research · 2021Article
- Trends in Childhood Poison Exposures and Fatalities: A Retrospective Secondary Data Analysis of the 2009-2019 U.S. National Poison Data System Annual Reports.Pediatric reports · 2021Article
- Parental perception of medications safe storage in the State of Qatar.Journal of family medicine and primary care · 2021Article
- Article
- Association of Selective Serotonin Reuptake Inhibitors With the Risk of Type 2 Diabetes in Children and Adolescents.JAMA psychiatry · 2021Article
- Circumstances Involved in Unsupervised Solid Dose Medication Exposures among Young Children.The Journal of pediatrics · 2020Article
- Unsafe storage of household medicines: results from a cross-sectional study of four-year-olds from the 2004 Pelotas birth cohort (Brazil).BMC pediatrics · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundAfter reports of increasing emergency department (ED) visits for unsupervised pediatric medication exposures in the 2000s, renewed efforts to improve safety packaging and education were initiated. National data on current trends can help further target interventions.
methodsWe used nationally representative data from the National Electronic Injury Surveillance System-Cooperative Adverse Drug Event Surveillance project (2004-2013) to assess trends in ED visits for unsupervised medication exposures in children aged <6 years. For 2010 through 2013, the dosage form and prescription status of implicated medications were identified.
resultsBased on 13,268 cases, there were an estimated 640,161 ED visits (95% confidence interval: 512,885 to 767,436) for unsupervised medication exposures from 2004 through 2013. From 2004 through 2010, ED visits for unsupervised exposures increased by an average of 5.7% annually, peaking at 75,842. After 2010, this trend reversed, and visits decreased by an average of 6.7% annually to 59,092 in 2013. From 2010 through 2013, 91.0% of unsupervised exposure visits involved 1 medication, most commonly an oral prescription solid (45.9%), oral over-the-counter (OTC) solid (22.3%), or oral OTC liquid (12.4%). More than 260 different prescription solids were implicated; opioids (13.8%) and benzodiazepines (12.7%) were the most common classes. Four medications were implicated in 91.2% of OTC liquid exposure visits: acetaminophen (32.9%), cough and cold remedies (27.5%), ibuprofen (15.7%), and diphenhydramine (15.6%).
conclusionsTargeting prevention efforts based on harm frequency and intervention feasibility can lead to continued reductions in ED visits for pediatric medication exposures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.